These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 9707350

  • 1. Ambulatory 24-hour blood pressure recordings in patients with Parkinson's disease with or without fludrocortisone.
    Hakamäki T, Rajala T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):367-9. PubMed ID: 9707350
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
    Schreglmann SR, Büchele F, Sommerauer M, Epprecht L, Kägi G, Hägele-Link S, Götze O, Zimmerli L, Waldvogel D, Baumann CR.
    Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension.
    Senard JM, Chamontin B, Rascol A, Montastruc JL.
    Clin Auton Res; 1992 Apr; 2(2):99-104. PubMed ID: 1638111
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.
    Pathak A, Senard JM.
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):393-403. PubMed ID: 15151485
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of L-threo-Dops on orthostatic hypotension in Parkinson's disease].
    Yanagisawa N, Ikeda S, Hashimoto T, Hanyu N, Nakagawa S, Fujimori N, Ushiyama M.
    No To Shinkei; 1998 Feb; 50(2):157-63. PubMed ID: 9513205
    [Abstract] [Full Text] [Related]

  • 9. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.
    Schoffer KL, Henderson RD, O'Maley K, O'Sullivan JD.
    Mov Disord; 2007 Aug 15; 22(11):1543-9. PubMed ID: 17557339
    [Abstract] [Full Text] [Related]

  • 10. Fludrocortisone for orthostatic hypotension.
    Veazie S, Peterson K, Ansari Y, Chung KA, Gibbons CH, Raj SR, Helfand M.
    Cochrane Database Syst Rev; 2021 May 17; 5(5):CD012868. PubMed ID: 34000076
    [Abstract] [Full Text] [Related]

  • 11. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).
    Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G.
    Mov Disord; 2015 Apr 15; 30(5):646-54. PubMed ID: 25487613
    [Abstract] [Full Text] [Related]

  • 12. Lower vascular tone and larger plasma volume in Parkinson's disease with orthostatic hypotension.
    Groothuis JT, Esselink RA, Seeger JP, van Aalst MJ, Hopman MT, Bloem BR.
    J Appl Physiol (1985); 2011 Aug 15; 111(2):443-8. PubMed ID: 21636563
    [Abstract] [Full Text] [Related]

  • 13. Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease.
    Hellman AM, Shah SP, Pawlowski SM, Duda JE, Morley JF.
    Parkinsonism Relat Disord; 2015 Jul 15; 21(7):723-8. PubMed ID: 25940998
    [Abstract] [Full Text] [Related]

  • 14. Orthostatic hypotension and ambulatory blood pressure monitoring.
    Zachariah PK, Krier J, Schwartz GL.
    J Hypertens Suppl; 1991 Dec 15; 9(8):S78-80. PubMed ID: 1795212
    [Abstract] [Full Text] [Related]

  • 15. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A).
    Hauser RA, Hewitt LA, Isaacson S.
    J Parkinsons Dis; 2014 Dec 15; 4(1):57-65. PubMed ID: 24326693
    [Abstract] [Full Text] [Related]

  • 16. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
    Isaacson SH, Skettini J.
    Vasc Health Risk Manag; 2014 Dec 15; 10():169-76. PubMed ID: 24729712
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased baroreflex sensitivity in Parkinson's disease is associated with orthostatic hypotension.
    Blaho A, Šutovský S, Valkovič P, Šiarnik P, Sýkora M, Turčáni P.
    J Neurol Sci; 2017 Jun 15; 377():207-211. PubMed ID: 28477697
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ, Neutel J.
    Ther Adv Cardiovasc Dis; 2010 Oct 15; 4(5):285-93. PubMed ID: 20801941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.